Mumbai-based Alkem Laboratories announced today the launch of generic empagliflozin and its combinations in India under the brand name “Empanorm.” The medication, which treats type-2 diabetes ...

Alkem Laboratories Ltd on Wednesday announced the launch of generic empagliflozin and its combinations in India. The formulation will launched under the brand name ‘Empanorm’ at prices that ...

According to the block deal data available on the National Stock Exchange (NSE), SBI Mutual Fund acquired 6.41 lakh shares or 0.54 per cent stake in Mumbai-headquartered Alkem Laboratories. The shares ...

Alkem Laboratories Ltd share price was up by 2.36% from the previous closing price of ₹4,706.95. Who are peers of Alkem Laboratories Ltd? The peers of Alkem Laboratories Ltd are Sun ...

India-focused drug makers like Mankind Pharma, Alkem Laboratories, Glenmark Pharmaceuticals, and Corona Remedies rolled out generic versions of empagliflozin on Wednesday, priced 80-90% lower than ...

The following block and bulk deals took place of both exchanges on February 21. Samprada & Nanhamati Singh Family Trust sold 6,41,712 shares (0.54 percent stake) of Alkem Laboratories Ltd in a ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The market closed moderately lower amid consolidation, but formed a bullish candlestick pattern on the daily charts, and the market breadth remained positive, given the continuation of buying ...

Pharmaceutical company Alkem Laboratories Ltd on Thursday (March 13) announced that the United States Food and Drug Administration (US FDA) conducted a Bioresearch Monitoring (BIMO) inspection at its ...

Alkem Laboratories has launched a generic medication for type-2 diabetes, chronic kidney disease and heart failure in India under the brand name Empanorm, offering prices 80% lower than innovator ...

SBI Mutual Fund on Friday bought additional shares of pharmaceutical company Alkem Laboratories for Rs 300 crore through an open market transaction. According to the block deal data available on the ...